Global DNA Methylation Conversion Kit Market Growth 2025-2031
Description
The global DNA Methylation Conversion Kit market size is predicted to grow from US$ 241 million in 2025 to US$ 435 million in 2031; it is expected to grow at a CAGR of 10.4% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The methylation conversion kit is a molecular biology tool used for DNA methylation research. It mainly converts unmethylated cytosine (C) into uracil (U) through bisulfite treatment, while methylated cytosine remains unchanged. This conversion allows researchers to distinguish methylated and unmethylated regions in DNA through subsequent PCR or sequencing methods, thereby achieving precise research at the epigenetic level. This type of kit is widely used in the fields of early cancer screening, developmental biology, and environmentally induced gene regulation research.
In terms of price, the methylation conversion kits of mainstream brands on the market such as Zymo Research, QIAGEN, Thermo Fisher, etc. usually cost between RMB 1,500 and RMB 5,000, depending on the throughput of the kit (such as 50 or 100 reactions), purification process (column purification or magnetic bead purification), and whether the components required for subsequent PCR are included. In recent years, some domestic brands have also launched cost-effective alternative products, with prices that can be reduced to less than RMB 1,000, which are especially suitable for teaching or primary scientific research purposes.
From the development trend, methylation conversion technology is evolving towards automation, rapidity and high sensitivity. For example, in recent years, ultra-fast processing solutions compatible with high-throughput sequencing have emerged, shortening the conversion time from the traditional 12 hours to less than 1 hour, while improving the DNA fidelity to meet the needs of single-cell methylome research. In addition, with the rise of liquid biopsy technology, the need to detect low-level methylation signals has prompted the continuous optimization of kits in terms of sensitivity and sample adaptability, and in the future it may form an integrated solution with artificial intelligence-assisted analysis software.
United States market for DNA Methylation Conversion Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for DNA Methylation Conversion Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for DNA Methylation Conversion Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key DNA Methylation Conversion Kit players cover New England Biolabs, Thermo Fisher Scientific Inc, Abcam, Merck, Vazyme, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “DNA Methylation Conversion Kit Industry Forecast” looks at past sales and reviews total world DNA Methylation Conversion Kit sales in 2024, providing a comprehensive analysis by region and market sector of projected DNA Methylation Conversion Kit sales for 2025 through 2031. With DNA Methylation Conversion Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Methylation Conversion Kit industry.
This Insight Report provides a comprehensive analysis of the global DNA Methylation Conversion Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DNA Methylation Conversion Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Methylation Conversion Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Methylation Conversion Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Methylation Conversion Kit.
This report presents a comprehensive overview, market shares, and growth opportunities of DNA Methylation Conversion Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Column-based
Magnetic Bead-based
Segmentation by Application:
Research Institutions
Medical Institutions
University Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
New England Biolabs
Thermo Fisher Scientific Inc
Abcam
Merck
Vazyme
Mgi-tech
Tiangen
illumina
Bestbaiao
Nanodigmbio (Nanjing) Biotechnology Co., Ltd.
Agenabio
Zymoresearch
A&A Biotechnology
QIAGEN
Yeasen
Key Questions Addressed in this Report
What is the 10-year outlook for the global DNA Methylation Conversion Kit market?
What factors are driving DNA Methylation Conversion Kit market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do DNA Methylation Conversion Kit market opportunities vary by end market size?
How does DNA Methylation Conversion Kit break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The methylation conversion kit is a molecular biology tool used for DNA methylation research. It mainly converts unmethylated cytosine (C) into uracil (U) through bisulfite treatment, while methylated cytosine remains unchanged. This conversion allows researchers to distinguish methylated and unmethylated regions in DNA through subsequent PCR or sequencing methods, thereby achieving precise research at the epigenetic level. This type of kit is widely used in the fields of early cancer screening, developmental biology, and environmentally induced gene regulation research.
In terms of price, the methylation conversion kits of mainstream brands on the market such as Zymo Research, QIAGEN, Thermo Fisher, etc. usually cost between RMB 1,500 and RMB 5,000, depending on the throughput of the kit (such as 50 or 100 reactions), purification process (column purification or magnetic bead purification), and whether the components required for subsequent PCR are included. In recent years, some domestic brands have also launched cost-effective alternative products, with prices that can be reduced to less than RMB 1,000, which are especially suitable for teaching or primary scientific research purposes.
From the development trend, methylation conversion technology is evolving towards automation, rapidity and high sensitivity. For example, in recent years, ultra-fast processing solutions compatible with high-throughput sequencing have emerged, shortening the conversion time from the traditional 12 hours to less than 1 hour, while improving the DNA fidelity to meet the needs of single-cell methylome research. In addition, with the rise of liquid biopsy technology, the need to detect low-level methylation signals has prompted the continuous optimization of kits in terms of sensitivity and sample adaptability, and in the future it may form an integrated solution with artificial intelligence-assisted analysis software.
United States market for DNA Methylation Conversion Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for DNA Methylation Conversion Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for DNA Methylation Conversion Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key DNA Methylation Conversion Kit players cover New England Biolabs, Thermo Fisher Scientific Inc, Abcam, Merck, Vazyme, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “DNA Methylation Conversion Kit Industry Forecast” looks at past sales and reviews total world DNA Methylation Conversion Kit sales in 2024, providing a comprehensive analysis by region and market sector of projected DNA Methylation Conversion Kit sales for 2025 through 2031. With DNA Methylation Conversion Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Methylation Conversion Kit industry.
This Insight Report provides a comprehensive analysis of the global DNA Methylation Conversion Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DNA Methylation Conversion Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Methylation Conversion Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Methylation Conversion Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Methylation Conversion Kit.
This report presents a comprehensive overview, market shares, and growth opportunities of DNA Methylation Conversion Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Column-based
Magnetic Bead-based
Segmentation by Application:
Research Institutions
Medical Institutions
University Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
New England Biolabs
Thermo Fisher Scientific Inc
Abcam
Merck
Vazyme
Mgi-tech
Tiangen
illumina
Bestbaiao
Nanodigmbio (Nanjing) Biotechnology Co., Ltd.
Agenabio
Zymoresearch
A&A Biotechnology
QIAGEN
Yeasen
Key Questions Addressed in this Report
What is the 10-year outlook for the global DNA Methylation Conversion Kit market?
What factors are driving DNA Methylation Conversion Kit market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do DNA Methylation Conversion Kit market opportunities vary by end market size?
How does DNA Methylation Conversion Kit break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
108 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for DNA Methylation Conversion Kit by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for DNA Methylation Conversion Kit by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
